本文選題：埋線 + 特發(fā)性肺纖維化�。� 參考：《時(shí)珍國醫(yī)國藥》2017年01期

【摘要】：目的評價(jià)埋線療法在治療早中期特發(fā)性肺纖維化的臨床療效和安全性。方法將80例患者隨機(jī)分為埋線組和對照組各40例;對照組采用西藥常規(guī)治療,埋線組在對照組的基礎(chǔ)上,加用埋線進(jìn)行治療,療程3月;用數(shù)理統(tǒng)計(jì)法分析患者治療前后在CT檢查、血?dú)夥治�、生活質(zhì)量方面的改善情況。結(jié)果治療3個(gè)月后,肺CT顯示,在磨玻璃影和網(wǎng)格影方面,兩組治療前后及治療后組間比較,均有統(tǒng)計(jì)學(xué)意義(P0.05)。血?dú)夥治鲋?在Pa O2、Sa O2、Pa CO2三方面,兩組治療前后及治療后組間比較,均有統(tǒng)計(jì)學(xué)意義(P0.05);在T-CO2方面,兩組治療前后有統(tǒng)計(jì)學(xué)差異(P0.05),治療后組間比較無統(tǒng)計(jì)學(xué)意義(P0.05)。生活質(zhì)量比較,在癥狀部分、總分和活動(dòng)部分3方面,埋線組治療前后及治療后組間比較,均有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論埋線治療可以改善早中期特發(fā)性肺纖維化患者的肺CT征象,增強(qiáng)肺功能,提高生活質(zhì)量,而且安全、方便,無不良反應(yīng)。
[Abstract]:Objective to evaluate the efficacy and safety of catgut embedding therapy in the treatment of early and mid-term idiopathic pulmonary fibrosis. Methods 80 patients were randomly divided into catgut embedding group (n = 40) and control group (n = 40). The improvement of CT examination, blood gas analysis and quality of life of patients before and after treatment were analyzed by mathematical statistics. Results after 3 months of treatment, lung CT showed that there was significant difference between the two groups before and after treatment in terms of glass-grinding and meshwork, and there was significant difference between the two groups before and after treatment (P 0.05). In blood gas analysis, there was significant difference between the two groups before and after treatment in three aspects of Pa O 2 O 2 Pa CO2, and in T-CO2, there was a significant difference between the two groups before and after treatment (P 0 05), but there was no significant difference between the two groups after treatment (P 0 05). The comparison of quality of life in the symptom part, total score and activity part, before and after treatment in the embedding group, there were significant differences between the two groups (P 0.05). Conclusion Catgut embedding therapy can improve CT features, enhance lung function and improve quality of life in patients with idiopathic pulmonary fibrosis in early and middle stage, and is safe, convenient and without adverse reactions.
【作者單位】： 山西中醫(yī)學(xué)院附屬醫(yī)院;山西中醫(yī)學(xué)院中西醫(yī)結(jié)合臨床學(xué)院;山西省中醫(yī)院;
【基金】：山西省科技攻關(guān)項(xiàng)目(No.20140313009-12)
【分類號】：R563.9

【參考文獻(xiàn)】

相關(guān)期刊論文 前1條

1 于宗兵;;穴位埋線聯(lián)合麻杏石甘湯加味防治支氣管哮喘的臨床研究[J];中醫(yī)臨床研究;2014年28期

【共引文獻(xiàn)】

相關(guān)期刊論文 前1條

1 張賽男;王煦U，

本文編號：1967865